PONZ DE LEON, Maurizio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 37.414
EU - Europa 14.580
AS - Asia 14.237
SA - Sud America 2.045
AF - Africa 196
Continente sconosciuto - Info sul continente non disponibili 17
OC - Oceania 16
Totale 68.505
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 37.151
GB - Regno Unito 7.174
SG - Singapore 4.994
CN - Cina 4.736
HK - Hong Kong 1.881
BR - Brasile 1.709
SE - Svezia 1.548
DE - Germania 1.313
UA - Ucraina 1.066
IT - Italia 1.047
TR - Turchia 846
RU - Federazione Russa 649
VN - Vietnam 610
FI - Finlandia 599
KR - Corea 385
BG - Bulgaria 377
FR - Francia 263
IN - India 182
AR - Argentina 140
CA - Canada 135
ID - Indonesia 116
NL - Olanda 98
MX - Messico 85
BD - Bangladesh 79
BE - Belgio 78
IE - Irlanda 78
ZA - Sudafrica 72
JP - Giappone 69
EC - Ecuador 63
IQ - Iraq 52
ES - Italia 49
PK - Pakistan 35
PL - Polonia 35
AE - Emirati Arabi Uniti 33
CL - Cile 33
AT - Austria 32
CO - Colombia 30
MY - Malesia 29
RO - Romania 29
VE - Venezuela 29
LT - Lituania 28
CZ - Repubblica Ceca 24
UZ - Uzbekistan 23
PY - Paraguay 21
MA - Marocco 20
KE - Kenya 19
SA - Arabia Saudita 19
TN - Tunisia 19
NP - Nepal 18
EG - Egitto 17
AZ - Azerbaigian 16
DZ - Algeria 15
IR - Iran 14
AU - Australia 11
EU - Europa 11
IL - Israele 10
JO - Giordania 10
TH - Thailandia 10
DK - Danimarca 9
GR - Grecia 9
KZ - Kazakistan 8
PE - Perù 8
PT - Portogallo 8
CH - Svizzera 7
JM - Giamaica 7
PH - Filippine 7
TW - Taiwan 7
AL - Albania 6
DO - Repubblica Dominicana 6
KG - Kirghizistan 6
LK - Sri Lanka 6
A2 - ???statistics.table.value.countryCode.A2??? 5
BA - Bosnia-Erzegovina 5
BO - Bolivia 5
BY - Bielorussia 5
BZ - Belize 5
GA - Gabon 5
HR - Croazia 5
KW - Kuwait 5
LB - Libano 5
LV - Lettonia 5
NZ - Nuova Zelanda 5
PA - Panama 5
PR - Porto Rico 5
RS - Serbia 5
SN - Senegal 5
EE - Estonia 4
GE - Georgia 4
LU - Lussemburgo 4
NO - Norvegia 4
OM - Oman 4
UY - Uruguay 4
AM - Armenia 3
CR - Costa Rica 3
ET - Etiopia 3
GY - Guiana 3
LY - Libia 3
MD - Moldavia 3
MK - Macedonia 3
NI - Nicaragua 3
Totale 68.451
Salva come PNG Salva come JPEG
Città #
Southend 5.521
Fairfield 3.408
Singapore 3.305
Santa Clara 3.122
Woodbridge 2.650
Ashburn 2.478
Jacksonville 2.218
Houston 2.201
Hong Kong 1.875
Chandler 1.835
Hefei 1.744
Dearborn 1.426
Ann Arbor 1.336
Wilmington 1.314
Seattle 1.285
Chicago 1.251
Cambridge 1.115
Nyköping 895
Los Angeles 862
London 850
Beijing 784
Salt Lake City 541
Princeton 486
Izmir 462
Sofia 375
Eugene 367
Modena 364
San Diego 355
Seoul 350
Des Moines 283
The Dalles 274
Elk Grove Village 253
New York 243
Tampa 238
Moscow 222
Buffalo 211
Council Bluffs 204
Dallas 203
Helsinki 200
Ho Chi Minh City 196
Shanghai 168
São Paulo 140
Hanoi 138
Sterling 138
Lancaster 125
Columbus 119
Bremen 114
Munich 113
San Jose 103
Grafing 101
Falls Church 99
Miami 96
Frankfurt am Main 87
Milan 83
Jakarta 72
Boardman 71
Guangzhou 70
Phoenix 67
Dulles 66
Detroit 65
Brussels 61
Norwalk 61
Atlanta 57
Fremont 56
Kunming 56
Dublin 54
Nanjing 54
Tokyo 54
Rio de Janeiro 50
Belo Horizonte 47
Kent 47
Brooklyn 45
Kansas City 44
Pittsburgh 40
Turku 39
Jinan 38
Mexico City 36
Philadelphia 36
Chiswick 34
Montreal 34
Denver 33
Ottawa 33
Curitiba 32
Hounslow 32
Porto Alegre 32
San Mateo 32
Toronto 32
Changsha 31
Brasília 30
San Francisco 30
Stockholm 29
Chennai 28
Nuremberg 28
Orem 28
Boston 27
Johannesburg 27
Redwood City 27
Verona 27
Da Nang 26
Quito 25
Totale 50.869
Salva come PNG Salva come JPEG
Nome #
Estimates of cancer burden in Italy 647
Molecular genetic alterations and clinical features in early-onset colorectal carcinomas and their role for the recognition of hereditary cancer syndromes 404
Relationship between MUC5AC and altered expression of MLH1 protein in mucinous and non-mucinous colorectal carcinomas 401
Attenuated familial adenomatous polyposis and Muir-Torre syndrome linked to compound biallelic constitutional MYH gene mutations. 398
EUROCARE-3 summary: Cancer survival in Europe at the end of the 20th century 390
Attitude of the Italian general population towards prevention and screening of the most common tumors, with special emphasis on colorectal malignancies. 389
Myeloperoxidase-positive cell infiltration in colorectal carcinogenesis as indicator of colorectal cancer risk. 387
Lymph node micrometastasis and survival of patients with Stage i (Dukes' A) colorectal carcinoma 385
Differentiated Thyroid Carcinoma (DTC) in a Young Woman with Peutz-Jeghers Syndrome: are these Two Conditions Associated? 381
K-ras and p53 mutations in hereditary non-polyposis colorectal cancers 380
Survival, surgical management and perioperative mortality of colorectal cancer in the 21-year experience of a specialised registry 371
Long-term survey of patients with curable colorectal cancer with specific reference to the quality of life. 370
A two-locus model for hereditary non-polyposis colorectal cancer in Modena, Italy 369
Attenuated polyposis of the large bowel: a morphologic and molecular approach 365
K-ras and p53 mutations in human colorectal aberrant crypt foci 364
Cyclooxygenase-2 and Hypoxia-Inducible Factor-1 alpha protein expression is related to inflammation, and up-regulated since the early steps of colorectal carcinogenesis 360
Different phenotypes in Muir-Torre Syndrome: clinical and biomolecular characterization in two italian families 354
A genetic model for determining MSH2 and MLH1 carrier probabilities based on family history and tumor microsatellite instability. 351
Morphological and quantitative analysis of BCL6 expression in human colorectal carcinogenesis. 347
Microsatellite instability in multiple colorectal tumors 345
The influence of age on colonic epithelial cell proliferation 344
Pattern of cell kinetics in colorectal mucosa of patients with different types of adenomatous polyps of the large bowel 342
Analysis of telomere dynamics in peripheral blood cells from patients with Lynch syndrome 342
IDENTIFICATION OF HEREDITARY NONPOLYPOSIS COLORECTAL-CANCER IN THE GENERAL-POPULATION - THE 6-YEAR EXPERIENCE OF A POPULATION-BASED REGISTRY 331
Molecular screening for Hereditary Non Polyposis Colorectal Cancer (HNPCC): a prospective, population-based study 329
Incidence, clinical features and possible etiology of early onset (≤40 years) colorectal neoplasms. 327
Incidence and survival of patients with Dukes' A (stages T1 and T2) colorectal carcinoma: a 15-year population-based study. 327
Frequency of constitutional MSH6 mutations in a consecutive series of families with clinical suspicion of HNPCC. 323
Aberrant crypt foci in patients with colorectal cancer 318
Immunohistochemical expression of MYH protein can be used to identify patients with MYH-associated polyposis 318
An unusual case of familial adenomatous polyposis with very early symptom occurrence 316
The cause of colorectal cancer 315
Aetiology of colorectal cancer and relevance of monogenic inheritance. 315
Staging and survival of colorectal cancer: are we making progress? The 14-year experience of a Specialized cancer Registry 313
Clinical features and colorectal cancer survival: an attempt to explain differences between two different Italian regions. 309
Histology of aberrant crypt foci in the human colon 307
Genomic instability and target gene mutations in colon cancers with different degrees of allelic shifts 307
Survival analysis in families affected by hereditary non-polyposis colorectal cancer 307
Frequency and clinical features of multiple tumors of the large bowel in the general population and in patients with hereditary colorectal carcinoma 306
Relative role of APC and MUTYH mutations in the pathogenesis of familial adenomatous polyposis. 305
Argyrophilic nucleolar organizer regions and bromodeoxyuridine and h3-thymidine labelling indices in colorectal cancer 301
Problems in the identification of hereditary nonpolyposis colorectal cancer in two families with late development of full-blown clinical spectrum 293
Epidemiology of colorectal cancer: the 21-year experience of a specialised registry. 290
Matrix metalloproteinases 15 and 19 are stromal regulators of colorectal cancer development from the early stages 288
Small bowel carcinoma in hereditary nonpolyposis colorectal cancer 287
Th Inducing POZ-Kruppel Factor (ThPOK) Is a Key Regulator of the Immune Response since the Early Steps of Colorectal Carcinogenesis 286
Double heterozygosity for BRCA1 and hMLH1 gene mutations in a 46-year-old woman with five primary tumors 285
A mononucleotide markers panel to identify hMLH1/hMSH2 germline mutations 284
Clinical features of colorectal cancer patients in advanced age: a population-based approach 282
Methylation pattern of different regions of the MLH1 promoter and silencing of gene expression in hereditary and sporadic colorectal cancer. 280
Identification of Muir-Torre Syndrome among patients with sebaceous tumors and keratoacanthomas: role of clinical features, microsatellite instability and immunohistochemistry 279
Investigation of APC mutations in a Turkish familial adenomatous polyposis family by heterodublex analysis 274
Clinical outcome of low- and high-risk malignant colorectal polyps: results of a population-based study and meta-analysis of the available literature 274
Decrease in plasma tryptophan after a tryptophan-free amino acid solution. A comparison between cirrhotic and control subjects 273
PLZF expression during colorectal cancer development and in normal colorectal mucosa according to body size, as marker of colorectal cancer risk. 273
Aberrant DNA methylation profiles of inherited and sporadic colorectal cancer 269
First observation of microadenomas in the ileal mucosa of patients with familial adenomatous polyposis and colectomies 269
Infliximab-related hepatitis: discussion of a case and review of the literature. 268
Biologic characterization of Hereditary Non-Polyposis Colorectal Cancer. Nuclear ploidy, AgNOR count, microvessel distribution, oncogene expression, and grade-related parameters. 267
Carcinoma papillare e Sindrome di Peutz-Jeghers: una rara associazione 263
Cholesterol esterase activity of human intestinal mucosa 259
Microsatellite instability and colorectal cancer prognosis. 257
Hereditary colorectal cancer in the general population: from cancer registration to molecular diagnosis 257
Stage I colorectal carcinoma: VEGF immunohistochemical expression, microvessel density, and their correlation with clinical outcome. 256
Clinical features, frequency and prognosis of Dukes' a colorectal carcinoma: A population-based investigation 256
Lymph node evaluation in stage IIA colorectal cancer and its impact on patient prognosis: A population-based study 254
Alteration of drug metabolism during cholestasis in man 252
Effect of the selective expansion of cholic acid pool on bile lipid composition: possible mechanism of bile acid induced biliary cholesterol desaturation. 251
Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE--5-a population-based study 250
Cancer prevalence in Italian cancer registry areas: The ITAPREVAL study 249
Clinical and molecular features of attenuated adenomatous polyposis in northern Italy. 247
The perception of health-related quality of life in colon cancer patients during chemotherapy: differences between men and women 246
Trend of incidence, subsite distribution and staging of colorectal neoplasms in the 15-year experience of a specialised cancer registry. 246
Analysis of mismatch repair gene mutations in Turkish HNPCC patients. 244
A founder MLH1 mutation in families from the districts of Modena and Reggio-Emilia in northern Italy with hereditary non-polyposis colorectal cancer associated with protein elongation and instability. 243
Diagnosis of hereditary non-polyposis colorectal cancer (HNPCC) [2] (multiple letters) 243
Familial aggregation of tumors and detection of hereditary non-polyposis colorectal cancer in 3-year experience of 2 population-based colorectal-cancer registries 243
A case of pneumatosis cystoides intestinalis mimicking familial adenomatous polyposis 240
Risk of colorectal polyps and of malignancies in asymptomatic carriers of mutations in the main DNA mismatch repair genes 240
Prognostic significance of histological features and biological parameters in stage I (pT1 and pT2) colorectal adenocarcinoma 240
Preventive war and chemoprevention of cancer 240
L'immunoistochimica delle proteine del mismatch repair può essere un utile test per identificare i pazienti HNPCC? 239
Risk of cancer revealed by follow-up of families with hereditary non-polyposis colorectal cancer: a population-based study 237
I tumori in Italia. Rapporto 2011: La sopravvivenza dei pazienti oncologici in Italia 237
Disease presentation, treatment and survival for Italian colorectal cancer patients: a EUROCARE high resolution study 237
Bile acid feeding and hepatic sterol metabolism: effect of deoxycholic acid. 235
Antioxidant vitamins and colorectal adenoma 233
In response. Adjuvant chemotherapy in colorectal cancer patients with microsatellite instability. 233
Clinical and molecular diagnosis of hereditary non-polyposis colorectal cancer: problems and pitfalls in an extended pedigree 230
Incidence trend of malignant polyps through the data of a specialized colorectal cancer registry: clinical features and effect of screening. 229
Colorectal carcinoma grading by quantifying poorly differentiated cell clusters is more reproducible and provides more robust prognostic information than conventional grading. 229
Alteration of drug metabolism in Gilbert's syndrome 228
Effects of acute changes of bile acid pool composition on biliary lipid secretion 227
Genetic testing among high-risk individuals in families with hereditary non polyposis colorectal cancer 227
Colorectal carcinoma in different age groups: A population based investigation 226
O6-methylguanine-DNA methyltransferase promoter hypermethylation in colorectal carcinogenesis 225
Epithelial cell kinetics in the remaining colorectal mucosa after surgery for cancer of the large bowel 225
Neutrophil gelatinase-associated lipocalin (NGAL) and matrix metalloproteinase-9 (MMP-9) prognostic value in stage I colorectal carcinoma. 225
Intestinal solubilization, absorption, pharmacokinetics and bioavailability of chenodeoxycholic acid. 222
EUROCARE-3: survival of cancer patients diagnosed 1990–94—results and commentary 222
Totale 29.323
Salva come PNG Salva come JPEG
Categoria #
all - tutte 280.971
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 280.971
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213.149 0 0 0 0 0 0 641 843 276 755 352 282
2021/20225.836 154 907 466 488 134 285 358 273 633 392 1.072 674
2022/20235.088 686 528 321 499 628 951 66 451 608 35 189 126
2023/20243.078 120 211 186 190 799 257 298 435 81 47 98 356
2024/202511.798 445 117 146 870 2.404 1.693 767 654 1.310 708 1.238 1.446
2025/202615.859 1.449 1.011 2.235 3.595 5.892 1.675 2 0 0 0 0 0
Totale 68.771